Jpmorgan Chase & Co »

Arbutus Biopharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $289k 116k 2.50
2023-09-30 $242k 119k 2.03
2023-06-30 $242k 105k 2.30
2023-03-31 $627k 207k 3.03
2022-12-31 $170k 73k 2.34
2022-06-30 $169k 64k 2.63
2022-03-31 $175k 59k 2.96
2021-12-31 $166k 43k 3.89
2021-03-31 $0 35k 0.00
2020-12-31 $0 36 0.00
2020-06-30 $0 33 0.00
2019-09-30 $145k 95k 1.52
2019-06-30 $688k 304k 2.26
2019-03-31 $2.8M 778k 3.58
2018-12-31 $46k 12k 3.88
2018-09-30 $979k 104k 9.45
2018-06-30 $1.6M 218k 7.25
2018-03-31 $1.1M 222k 5.00
2017-12-31 $898k 178k 5.05
2017-06-30 $24k 6.7k 3.60
2017-03-31 $25k 7.6k 3.29
2016-12-31 $24k 9.7k 2.47
2016-06-30 $6.0k 1.4k 4.29